CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,134,778
- in 1 filing
Net −$9,134,778. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Chevallard Daniel R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +14,000 | 14,000 | ||
| 2025-11-17 | Olsson Shawn Chief Commercial Officer | Option exercise 10b5-1 | +10,000 | $2.08 | $21K | 14,733 |
| 2025-11-17 | Olsson Shawn Chief Commercial Officer | Sale 10b5-1 | −4,212 | $25.74 | $108K | 10,521 |
| 2025-11-17 | Olsson Shawn Chief Commercial Officer | Sale 10b5-1 | −5,788 | $26.37 | $153K | 4,733 |
| 2025-11-17 | Olsson Shawn Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 53,241 | ||
| 2025-11-07 | MCCOLLUM JAMES W Director | Purchase | +10,500 | $22.79 | $239K | 10,500 |
| 2025-11-07 | Chevallard Daniel R. Chief Financial Officer | Purchase | +20 | $22.71 | $454 | 3,208 |
| 2025-11-07 | Chevallard Daniel R. Chief Financial Officer | Purchase | +2,178 | $22.76 | $50K | 5,386 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −49,701 | $45.35 | $2.3M | 1,133,842 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −34,405 | $45.35 | $1.6M | 821,752 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −83,066 | $46.41 | $3.9M | 1,050,776 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −57,502 | $46.41 | $2.7M | 764,250 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −177 | $47.01 | $8K | 1,050,599 |
| 2025-09-30 | Versant Venture Capital VI, L.P. 10% owner | Sale | −123 | $47.01 | $6K | 764,127 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −49,479 | $41.59 | $2.1M | 1,224,718 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −24,370 | $41.59 | $1.0M | 876,437 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −40,907 | $43.00 | $1.8M | 1,183,811 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −20,148 | $43.00 | $866K | 856,289 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −268 | $43.30 | $12K | 1,183,543 |
| 2025-09-18 | Versant Venture Capital VI, L.P. 10% owner | Sale | −132 | $43.30 | $6K | 856,157 |
Page 2 of 11 · 217 trades